Leaders in the U.S. Senate aim to repeal one of the least popular provisions of the Patient Protection and Affordable Care Act: The 2.3 percent excise tax on manufacturers and importers of medical devices.
The tax has been criticized by trade groups as costing jobs, and it appears to be falling well short of expectations in raising revenue.
Although a bipartisan coalition in the House of Representatives pushed through legislation in June to undo the tax, which is expected to bring in $30 billion over ten years, the bill will not become law until the Senate acts. But Democratic and Republican aides told the National Journal that the upper chamber will soon address the issue.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
